Ascendis Pharma A/S
ASND
$223.82
-$3.59-1.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 723.31M | 632.51M | 580.21M | 559.80M | 579.30M |
| Total Receivables | 185.15M | 172.77M | 142.36M | 83.03M | 183.70M |
| Inventory | 354.04M | 354.36M | 356.29M | 316.77M | 306.05M |
| Prepaid Expenses | 39.59M | 34.51M | 40.29M | 36.39M | 29.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.30B | 1.19B | 1.12B | 995.99M | 1.10B |
|
|
|||||
| Total Current Assets | 1.30B | 1.19B | 1.12B | 995.99M | 1.10B |
| Net Property, Plant & Equipment | 171.98M | 119.40M | 109.86M | 99.92M | 102.20M |
| Long-term Investments | 4.10M | -- | -- | -- | 3.62M |
| Goodwill | 4.10M | -- | -- | -- | 3.62M |
| Total Other Intangibles | 252.40K | 4.39M | 4.45M | 4.23M | 551.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.76M | 3.71M | 3.18M | 2.87M | 2.40M |
| Total Assets | 1.53B | 1.35B | 1.28B | 1.15B | 1.22B |
|
|
|||||
| Total Accounts Payable | 106.44M | 92.22M | 110.06M | 91.19M | 99.80M |
| Total Accrued Expenses | -- | 56.66M | 46.89M | 41.14M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 571.25M | 565.86M | 542.98M | 529.57M | 508.89M |
| Total Finance Division Other Current Liabilities | 577.91M | 442.69M | 398.13M | 295.20M | 331.23M |
| Total Other Current Liabilities | 577.91M | 442.69M | 398.13M | 295.20M | 331.23M |
| Total Current Liabilities | 1.26B | 1.16B | 1.10B | 957.10M | 939.91M |
|
|
|||||
| Total Current Liabilities | 1.26B | 1.16B | 1.10B | 957.10M | 939.91M |
| Long-Term Debt | 298.42M | 290.45M | 298.91M | 300.56M | 297.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 153.91M | 98.35M | 88.86M | 85.64M | 80.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.62M | 12.87M | 12.08M | 9.11M | 12.69M |
| Total Liabilities | 1.72B | 1.56B | 1.50B | 1.35B | 1.33B |
|
|
|||||
| Common Stock & APIC | 2.98B | 2.96B | 2.91B | 2.67B | 2.54B |
| Retained Earnings | -3.17B | -3.16B | -3.13B | -2.87B | -2.65B |
| Treasury Stock & Other | -2.15M | -1.58M | 268.90K | 1.76M | 1.73M |
| Total Common Equity | -191.17M | -204.24M | -220.28M | -205.15M | -109.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -191.17M | -204.24M | -220.28M | -205.15M | -109.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -191.17M | -204.24M | -220.28M | -205.15M | -109.44M |
|
|
|||||